To include your compound in the COVID-19 Resource Center, submit it here.

Pracinostat: Completed Phase II enrollment

MEI completed enrollment of 108 patients with previously untreated intermediate-2 or high-risk MDS in a double-blind, placebo-controlled, U.S.

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE